[1] |
杨林东,杨露,孙丽洲.围生期新生儿不同血清型B族链球菌感染及其预防研究现状 [J/CD].中华妇幼临床医学杂志(电子版),2017,13(6): 621-626.
|
[2] |
Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and Meta-analysis[J]. Lancet, 2012, 379(9815): 547-556.
|
[3] |
Tevdorashvili G, Tevdorashvili D, Andghuladze M, et al. Prevention and treatment strategy in pregnant women with group B streptococcal infection[J]. Georgian Med News, 2015, 241(1): 15-23.
|
[4] |
Simonsen KA, Anderson-Berry AL, Delair SF, et al. Early-onset neonatal sepsis[J]. Clin Microbiol Rev, 2014, 27(1): 21-47.
|
[5] |
Melin P. Neonatal group B streptococcal disease: from pathogenesis to preventive strategies[J]. Clin Microbiol Infect, 2011, 17(9): 1294-1303.
|
[6] |
Le Doare K, Heath PT. An overview of global GBS epidemiology[J]. Vaccine, 2013, 31(Suppl 4): D7- D12.
|
[7] |
Adair CE, Kowalsky L, Quon H, et al. Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study[J]. CMAJ, 2003, 169(3): 198-203.
|
[8] |
Dangor Z, Kwatra G, Izu A, et al. HIV-1 is associated with lower group B Streptococcus capsular and surface-protein IgG antibody levels and reduced transplacental antibody transfer in pregnant women[J]. J Infect Dis, 2015, 212(3): 453-462.
|
[9] |
Pintye J, Saltzman B, Wolf E, et al. Risk factors for late-onset group B streptococcal disease before and after implementation of universal screening and intrapartum antibiotic prophylaxis[J]. J Pediatric Infect Dis Soc, 2016, 5(4): 431-438.
|
[10] |
Libster R, Edwards KM, Levent F, et al. Long-term outcomes of group B streptococcal meningitis[J]. Pediatrics, 2012, 130(1): e8-e15.
|
[11] |
Verani JR, McGee L, Schrag SJ, et al. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010[J]. MMWR Recomm Rep, 2010, 59(RR-10): 1-36.
|
[12] |
Oddie S, Embleton ND. Risk factors for early onset neonatal group B streptococcal sepsis: case-control study[J]. BMJ, 2002, 325(7359): 308-310.
|
[13] |
Nuccitelli A, Rinaudo CD, Maione D. Group B Streptococcus vaccine: state of the art[J]. Ther Adv Vaccines, 2015, 3(3): 76-90.
|
[14] |
Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates[J]. N Engl J Med, 2002, 347(4): 233-239.
|
[15] |
Szymusik I, Kosińska-Kaczyińska K, Pietrzak B, et al. Do we need a different approach to GBS screening?[J]. Ginekol Pol, 2014, 85(6): 456-460.
|
[16] |
Kobayashi M, Vekemans J, Baker CJ, et al. Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries[J]. F1000Res, 2016, 5: 2355.
|
[17] |
World Health Organization. WHO Recommendations for prevention and treatment of maternal peripartum infections[M]. Geneva: World Health Organization, 2015.
|
[18] |
Ayieko P, Griffiths UK, Ndiritu M, et al. Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children[J]. PLoS One, 2013, 8(6): e67324.
|
[19] |
Fairlie T, Zell ER, Schrag S. Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease[J]. Obstet Gynecol, 2013, 121(3): 570-577.
|
[20] |
Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implycations for a potential group B streptococcal vaccine[J]. Vaccine, 2013, 31(Suppl 4): D20-D26.
|
[21] |
Heath PT. Status of vaccine research and development of vaccines for GBS [J]. Vaccine, 2016, 34(26): 2876-2879.
|
[22] |
Chen VL, Avci FY, Kasper DL. A maternal vaccine against group B Streptococcus: past, present, and future[J]. Vaccine, 2013, 31(Suppl 4): D13-D19.
|
[23] |
Dangor Z. Review on the association of group B Streptococcus capsular antibody and protection against invasive disease in infants[J]. Expert Rev Vaccines, 2015, 14(1): 135-149.
|